Literature DB >> 15186841

Design, synthesis, and structure-activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands.

Taketoshi Okubo1, Ryoko Yoshikawa, Shigeyuki Chaki, Shigeru Okuyama, Atsuro Nakazato.   

Abstract

The peripheral benzodiazepine receptor (PBR) is pharmacologically distinct from the central benzodiazepine receptor (CBR) and has been identified in a wide range of peripheral tissues as well as in the central nervous system. Although numerous studies have been performed of it, the physiological roles and functions of the PBR are still unclear. In the present study, in exploring new types of ligands for PBR, we found that a new series of compounds having a tetracyclic ring system, which were designed from FGIN-1-27, exhibited high affinities for PBR. We prepared and evaluated them for PBR affinities. The results of binding tests showed that 12e and 12f were the most potent PBR ligands among them (12e: IC(50)=0.44nM, 12f: IC(50)=0.37nM). In this paper, we present the design, synthesis, and structure-activity relationships (SARs) of novel tetracyclic compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186841     DOI: 10.1016/j.bmc.2004.04.025

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Reversing the direction in a light-driven rotary molecular motor.

Authors:  Nopporn Ruangsupapichat; Michael M Pollard; Syuzanna R Harutyunyan; Ben L Feringa
Journal:  Nat Chem       Date:  2010-10-31       Impact factor: 24.427

2.  Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.

Authors:  Pablo M Rusjan; Alan A Wilson; Peter M Bloomfield; Irina Vitcu; Jeffrey H Meyer; Sylvain Houle; Romina Mizrahi
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-27       Impact factor: 6.200

3.  Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.

Authors:  Romina Mizrahi; Pablo M Rusjan; James Kennedy; Bruce Pollock; Benoit Mulsant; Ivonne Suridjan; Vincenzo De Luca; Alan A Wilson; Sylvain Houle
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-04       Impact factor: 6.200

4.  Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).

Authors:  Romina Mizrahi; Pablo M Rusjan; Irina Vitcu; Alvina Ng; Alan A Wilson; Sylvain Houle; Peter M Bloomfield
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

5.  Fully automated synthesis and initial PET evaluation of [11C]PBR28.

Authors:  Min Wang; Karmen K Yoder; Mingzhang Gao; Bruce H Mock; Xiao-Ming Xu; Andrew J Saykin; Gary D Hutchins; Qi-Huang Zheng
Journal:  Bioorg Med Chem Lett       Date:  2009-08-15       Impact factor: 2.823

6.  Radiosynthesis of (R,S)-[18 F]GE387: A Potential PET Radiotracer for Imaging Translocator Protein 18 kDa (TSPO) with Low Binding Sensitivity to the Human Gene Polymorphism rs6971.

Authors:  Luxi Qiao; Emily Fisher; Lindsay McMurray; Selena Milicevic Sephton; Matthew Hird; Nisha Kuzhuppilly-Ramakrishnan; David J Williamson; Xiouyun Zhou; Eryn Werry; Michael Kassiou; Saijinder Luthra; William Trigg; Franklin I Aigbirhio
Journal:  ChemMedChem       Date:  2019-04-08       Impact factor: 3.466

7.  Improved Automated Radiosynthesis of [(11)C]PBR28.

Authors:  Kiran Kumar Solingapuram Sai; Don Gage; Mike Nader; Robert H Mach; Akiva Mintz
Journal:  Sci Pharm       Date:  2015-06-19

8.  [18F]FEPPA PET imaging for monitoring CD68-positive microglia/macrophage neuroinflammation in nonhuman primates.

Authors:  Matthew Zammit; Yunlong Tao; Miles E Olsen; Jeanette Metzger; Scott C Vermilyea; Kathryn Bjornson; Maxim Slesarev; Walter F Block; Kerri Fuchs; Sean Phillips; Viktorya Bondarenko; Su-Chun Zhang; Marina E Emborg; Bradley T Christian
Journal:  EJNMMI Res       Date:  2020-08-06       Impact factor: 3.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.